â– LECTURE OVERVIEW: Pharmacokinetics defines how the body handles a xenobiotic, focusing on the concentration-dependent kinetics of drug elimination.
â– KINETIC MECHANISMS:
1. First-Order Kinetics (Normal/Dominant):
- Definition: The rate of drug elimination is directly proportional to the plasma concentration of the drug.
- Half-Life Model: The drug exhibits a constant half-life (t1/2), meaning a constant fraction of the drug is eliminated per unit of time.
- Clearence Stability: Clearance is constant. Most clinical therapeutic agents obey first-order elimination across standard therapeutic ranges.
2. Zero-Order Kinetics (Saturation Kinetics):
- Definition: The rate of drug elimination is completely independent of plasma drug concentration. A constant amount of drug is eliminated per unit of time.
- Carrier Saturation: Occurs when the drug concentration exceeds the saturation point of metabolic enzymes or active transport clearance channels.
- Toxicity Risk: The half-life is variable (longer at higher concentrations). Continued administration easily leads to rapid, toxic drug accumulation.
â– PROGNOSTIC CRITERIA & TIMELINE:
Patient outcome scales correlate heavily with diagnostic staging at presentation, age, pre-existing comorbidities, and biological markers of cellular dividing rates.
â– EPIDEMIOLOGICAL PROFILE & DENSITY CORRELATIONS:
Global burden patterns reveal notable associations with lifestyle habits, regional environmental factors, and inherited traits.
[HY-BOARD-1349]
🌟 Dynamic Clinical Key:
Three classic substances exhibit saturated, zero-order kinetics at high or therapeutic doses: Ethanol, Phenytoin (epilepsy management), and High-dose Aspirin (salicylates). In these cases, minor dosage changes can lead to disproportionately massive spikes in serum levels and severe toxicity. Regularly reassess clinical parameters to adjust long-term therapy. Focus screening efforts on high-risk geographic regions to maximize clinical yield.